2 completed, 1 active not recruiting, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow Attenuated familial adenomatous polyposis: new trials by email Literature Review of Attenuated familial adenomatous polyposis trials Research Report on Attenuated familial adenomatous polyposis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Familial Adenomatous Poliposys Italian Network (Rete Italiana Poliposi Adenomatosa Familiare) Familial Adenomatous Polyposis (FAP), Attenuated Familial Adenomatous Polyposis (AFAP) | Active not recruiting | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 1500 | 2024-05-13 | 2026-03-10 | |
| Testing Obeticholic Acid for Familial Adenomatous Polyposis Biopsy Procedure, Biospecimen Collection, Gastrointestinal Endoscopy - Attenuated Familial Adenomatous Polyposis, Colorectal Carcinoma | Phase 2 | Terminated | National Cancer Institute (NCI) | 15 | 2023-01-19 | 2026-05-14 |
| Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer Erlotinib, Erlotinib Hydrochloride - Attenuated Familial Adenomatous Polyposis, Familial Adenomatous Polyposis | Phase 2 | Completed | National Cancer Institute (NCI) | 46 | 2017-10-27 | 2022-07-26 |
| Non-Surgical Management of Attenuated and Deleterious (Classical) Familial Adenomatous Polyposis: A Long-term Surveillance Program Chart Review - Attenuated Familial Adenomatous Polyposis, Deleterious Familial Adenomatous Polyposis | Completed | M.D. Anderson Cancer Center | 1500 | 2008-02-01 | 2022-09-02 |
Adenomatous Polyposis Coli (3) · Colorectal Neoplasms (2) · Desmoid Tumors (1) · Duodenal Neoplasms (1) · Gardner Syndrome (1) · Neoplastic Syndromes, Hereditary (1) · Polyposis Syndrome, Hereditary Mixed, 1 (1) · Turcot syndrome (1)
Adenoma (3) · Adenomatous Polyps (3) · Colonic Diseases (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Digestive System Diseases (3) · Digestive System Neoplasms (3) · Gastrointestinal Diseases (3) · Gastrointestinal Neoplasms (3) · Genetic Diseases, Inborn (3) · Intestinal Diseases (3) · Intestinal Neoplasms (3) · Intestinal Polyposis (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms by Site (3)
Biopsy (1) · Endoscopy, Gastrointestinal (1) · Erlotinib Hydrochloride (1) · Specimen Handling (1) · obeticholic acid (1)
National Cancer Institute (NCI) (2) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (1) · M.D. Anderson Cancer Center (1)
United States (3) · Puerto Rico (2) · Italy (1)
Eduardo Vilar-Sanchez (1) · Marco Vitellaro, MD (1) · Niloy J Samadder (1) · Patrick Lynch, MD, JD (1)
N01CN00042 (1), P30CA015083 (1), P30CA016672 (1), UG1CA242609 (1)